A. Lichtman

Immunology · 2000–2017

A researcher in the Science corpus: 4 papers; trusts 12 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Lichtman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peter Libby
  2. I. Tabas
  3. M. Perretti
  4. K. Bornfeldt
  5. C. Nathan
  6. M. Bennett
  7. P. Ridker
  8. Christian Weber
  9. Bennett G. Childs

Who trusts A. Lichtman overall

  1. M. Tsan

Papers from A. Lichtman's perspective

Ordered by how strongly the researchers A. Lichtman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Progress and challenges in translating the biology of atherosclerosis (Nature)
  2. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. (Journal of Clinical Investigation)
  3. Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency (Arteriosclerosis, Thrombosis and Vascular Biology)
  4. Mechanisms of acute coronary syndromes and their implications for therapy. (New England Journal of Medicine)
  5. Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation (PLoS ONE)
  6. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation (Science)
  7. Resolution of inflammation: state of the art, definitions and terms (The FASEB Journal)
  8. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (Nature reviews. Immunology)
  9. Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes (Arteriosclerosis, Thrombosis and Vascular Biology)
  10. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. (The Lancet)

Their papers